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The minnesota resuscitation consortium refractory VF early
mobilization protocol. one year report
D. Yannopoulos, D. Benditt, K. Lurie, E. Caldwell. University of Minnesota,
Cardiology, Minneapolis, United States of America
Background: In December of 2015, the Minnesota Resuscitation Consortium im-
plemented a systems-based protocol of early mobilization to a tertiary academic
hospital for patients presenting with out-of-hospital refractory shockable rhythms
(VF/VT). We report the outcomes of 63 patients treated within the 1st year of the
protocol.
Methods: Two major emergency medical services systems serving the
Minneapolis-St. Paul metro area participated in the protocol. Inclusion criteria in-
cluded age 18–75 years, body habitus accommodating automated LUCAS CPR,
and estimated transfer time from the scene to the cardiac catheterization labora-
tory of ≤30 minutes. Exclusion criteria included known terminal illness, DNR/DNI
status, traumatic arrest, and signiﬁcant bleeding. Refractory VF/VT arrest was de-
ﬁned as failure to achieve sustained ROSC after treatment with 3 direct current
(DC) shocks. Patients were transported to the University of Minnesota hospital
where emergent advanced perfusion strategies (ECMO), followed by coronary
angiography and PCI, were performed, when appropriate.
Results: Over the ﬁrst 12 months of the protocol, 63 patients were transported
directly to the cardiac catheterization laboratory. Of these, 50 patients met the
perfusion inclusion criteria upon arrival (lactic acid <18, ETCO2 >10mmHg,
SaO2>88%) and resuscitation efforts were continued ECMO was placed in 80%.
76% of patients had signiﬁcant coronary artery disease and 67% received PCI.
82% of patients survived to hospital admission and 52% (26/50) survived to hos-
pital discharge with 48% (24/50) achieving good neurologic function (CPC 1 and
2). Two patients developed signiﬁcant lower extremity ischemia due to ECMO but
had no chronic complications.
Conclusions: A systems based approach for the management of OHCA refrac-
tory VF/VT protocol with early mobilization to an ECMO /PCI capable hospital is
feasible in a large US metropolitan area and leads to a high functionally favorable
survival rate with few complications. A randomized trial is warranted.
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Duration for attaining favourable neurological outcome in refractory
out-of-hospital cardiac arrest patients who were resuscitated with
veno-arterial extracorporeal membrane oxygenation
T. Otani, R. Matsuoka, M. Morita, T. Natsukawa, H. Sawano, Y. Hayashi. Osaka
Saiseikai Senri Hospital, Senri Critical Care Medical Centre, Osaka, Japan
Introduction: Cardiopulmonary resuscitation (CPR) with veno-arterial extracor-
poreal membrane oxygenation (VA-ECMO) is useful for refractory out-of-hospital
cardiac arrest (OHCA) patients. However, the limit of cardiac arrest duration when
expecting a favourable neurological outcome is unknown.
Purpose: To assess the limit of cardiac arrest duration (interval from arrest to
ECMO) when expecting a favourable neurological outcome in refractory OHCA
patients who were resuscitated with VA-ECMO.
Methods: Between October 2009 and October 2016, we retrospectively anal-
ysed the data of witnessed refractory OHCA patients with shockable initial car-
diac rhythm who were admitted to our hospital and resuscitated with VA-ECMO.
We compared these data between favourable and unfavourable neurological out-
comes on the day of their discharge. The patients with non-cardiac cause of arrest
were excluded. Unfavourable neurological outcome was predicted using area un-
der receiver-operating characteristics (ROC) curves.
Results: In this study period, 73 refractory patients with OHCA were resuscitated
with VA-ECMO, and 4 patients’ cause of arrest was non-cardiac. Among the in-
cluded 69 patients, 62 (90%) were male, median age was 62 years (interquartile
range, 50–72 years), 33 (48%) received bystander CPR, 38 (55%) had acute my-
ocardial infarction (AMI), and 11 (16%) had a favourable neurological outcome.
Interval from arrest to ECMO was shorter (median 46 [interquartile range 42–48]
Figure 1. ROC curve of arrest duration.
Table 1. Comparison between 2 groups
Favourable neurological Unfavourable neurological P-value
outcome, n=11 outcome, n=58
Age, years 59 (44–74) 63 (50–72) 0.56
Male 9 (82) 53 (91) 0.31
Bystander CPR 6 (55) 27 (47) 0.75
AMI 4 (36) 34 (59) 0.20
Interval from arrest to ECMO, min 46 (42–48) 53 (46–63) 0.010
Data are presented as the number (%) of patients or median (interquartile range).
vs 53 [46–63], p=0.010) in the favourable neurological outcome group than in the
unfavourable out come group (Table 1). Areas under ROC curves revealed that
the accuracy of cardiac arrest duration in predicting an unfavourable neurological
outcome was 0.75 (95% conﬁdence interval 0.63–0.87). The cut-off value of 53
min corresponded to a sensitivity of 0.50 and a speciﬁcity of 1.0 (Fig. 1).
Conclusion: Resuscitation with VA-ECMO for witnessed refractory OHCA pa-
tients with shockable initial cardiac rhythm should be performed within 53 min.
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Higher survival rates in exercise-related out-of-hospital cardiac
arrests, compared to non-exercise-related cardiac arrests - a study
from the Swedish Register of Cardiopulmonary Resuscitation
M. Frisk Torell1, A. Stromsoe2, E. Zagerholm3, J. Herlitz4, A. Claesson5,
L. Svensson5, M. Borjesson3. 1Kungalv Hospital, Medicine, Kungalv, Sweden;
2Dalarna University, Falun, Sweden; 3Sahlgrenska Academy, Gothenburg,
Sweden; 4University of Boras, Boras, Sweden; 5Karolinska Institute, Stockholm,
Sweden
Background: Despite the positive effects of regular physical activity, the risk of a
sudden cardiac arrest (SCA) is transiently increased during and immediately af-
ter exercise. The total incidence of exercise-related out-of-hospital cardiac arrests
(OHCA) is however scarcely studied, and neither are prognosis and characteris-
tics of these events. One of the limiting factors for previous studies has been the
lack of comprehensive registries, to be able to detect the true incidence in the
whole population cohorts.
Purpose: To assess the incidence of exercise-related OHCAs in the general pop-
ulation of all ages and to compare characteristics and prognosis of these cardiac
arrests with non-exercise-related OHCAs.
Methods: All cases of OHCA outside of home reported to the Swedish Register
of Cardiopulmonary Resuscitation from 2011 to 2015 in three counties of Sweden
were included (population 2.1 million). This registry captures almost 100% of all
OHCAs in Sweden. Information on OCHAs regarding survival, treatment and di-
agnosis was obtained from the registry. Additional data variables were extracted
from EMS medical records and hospital medical records by a computer software.
Results: A total number of 1825 cases of OHCA outside of home where resus-
citation was attempted occurred in the three counties during the study period. Of
these 1825, 137 (7.5%) were exercise related, resulting in an incidence of 1.2 per
100.000 person-years. The 30-day survival rate was signiﬁcantly higher among
exercise-related OHCAs compared to non-exercise-related OHCAs (54.3% vs
19.4%, p<0.0001). Patients suffering an exercise-related OHCA were on average
10 years younger than those who had a non-exercise related OHCA, 56.4 years
compared to 67.2 years. Exercise-related OHCAs were more often witnessed
(89.4% vs 78.6%, p=0.002), had higher rates of bystander CPR (80.3% vs 61.0%,
p<0.0001) and patients in this group were more frequently connected to an AED
before arrival of EMS (20.4% vs 4.6%, p<0.0001) compared to cases of non-
exercise-related OCHAs. The sports activities most commonly associated with
exercise-related OHCA were cycling (20%), gym workout/group training (11%)
and golf (9%).
Discussion: The incidence of exercise-related OHCA in the general population
is 1.2 per 100.000 person-years. Cardiac arrests that occur in relation to exercise
have a signiﬁcantly better prognosis and outcome than non-exercise-related car-
diac arrests. This may be explained by favorable circumstances such as higher
degree of bystander CPR but may also reﬂect that these persons experience an
SCA at a lower degree of coronary artery disease, due to their younger age and
to exercise as a trigger.
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Linoleic acid in adipose tissue and risk of ischemic stroke
S.K. Venoe1, C.S. Bork1, M.U. Jakobsen2, S. Lundbye-Christensen3, F.W. Bach4,
E.B. Schmidt1, K. Overvad2. 1Aalborg University Hospital, Department of
Cardiology, Aalborg, Denmark; 2Aarhus University, Department of Public Health,
Section for Epidemiology, Aarhus, Denmark; 3Aalborg University Hospital, Unit of
Clinical Biostatistics and Bioinformatics, Aalborg, Denmark; 4Aarhus University
Hospital, Department of Neurology, Aarhus, Denmark
Background/Introduction: Linoleic acid, the predominant n-6 polyunsaturated
fatty acid, is known to reduce plasma low-density lipoprotein cholesterol and has
been recommended for prevention of coronary heart disease. Whether linoleic
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acid (LA) is associated with risk of ischemic stroke has not been investigated
thoroughly and the results of the few previous studies have been inconsistent.
Purpose: The aim of this study was to investigate the association between the
content of LA in adipose tissue, which is a long-term marker of endogenous ex-
posure to LA, and the risk of ischemic stroke.
Methods: The Danish cohort study Diet, Cancer and Health consists of 57,053
participants aged 50–64 years at baseline. At enrolment, all participants had an
adipose tissue biopsy taken. Information on ischemic stroke development during
follow-up was obtained from The Danish National Patient Register, and cases
were all validated. Cases and a random sample of 3,203 subjects, drawn from the
whole cohort had their fatty acid composition determined by gas chromatography
(wt%). Hazard ratios (HR) with 95% conﬁdence intervals (CI) across quartiles of
LA were calculated using a weighted Cox regression analysis.
Results: During a median of 13.5 years of follow-up 1,879 participants developed
ischemic stroke. Adipose tissue biopsies were available on 1,755 ischemic stroke
cases. After adjusting for appropriate risk factors, adipose tissue content of LA
was negatively associated with ischemic stroke. HR for ischemic stroke relative
to the lowest quartile of adipose LA contents was lower across quartiles, second
quartile (HR 0.92, 95% CI 0.77; 1.09), third (HR 0.85, 95% CI 0.71; 1.02) and
fourth (HR 0.78, 95% CI 0.65; 0.93).
Conclusion: The risk of ischemic stroke was negatively associated with the con-
tent of LA in adipose tissue suggesting a protective effect of LA against ischemic
stroke.
Acknowledgement/Funding: Danish Cancer Society. The Danish Heart Foun-
dation
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Assessment of vascular damage in hodgkin lymphoma survivors:
effect of radiotherapy
A. Paini1, M. Salvetti1, F. Bertacchini1, M. Buglione2, F. Tevisan2, L. Baushi2,
S.M. Magrini2, M.L. Muiesan1. 1University of Brescia, Internal Medicine, Brescia,
Italy; 2University of Brescia, Department of Radiation Oncology, Brescia, Italy
Background: New chemotherapeutic drugs and radiation therapy have signiﬁ-
cantly improved cancer patient’s survival, although the cardiovascular (CV) side
effects of cancer treatment are increasingly important. In previous studies, an
increased risk of cerebrovascular complications such as stroke and transient is-
chemic attack was described in patients undergoing neck radiotherapy.
Aim of our study was to evaluate vascular carotid structural (IMT, plaque) and
functional (carotid stiffness) damage, and changes in arterial stiffness (Carotido-
femoral pulse wave velocity; cf-PWV) in Hodgkin Lymphoma survivors previously
treated with radiotherapy.
Patients and methods: We enrolled 206 Hodgkin lymphoma survivors (mean
age 54±14 years, 51% males, mean follow-up of 9±6 years). CV risk factors
were investigated and atherosclerotic carotid damage was assessed by stan-
dard carotid ultrasound evaluation for intima-media thickness (IMT) measurement
(MeanMax-IMT, CBMax, Tmax; n=167); in 141 patienys radiofrequency-based
carotid stiffness analysis (distensibility; distensibility coefﬁcient, DC; compliance
coefﬁcient; CC) was also performed. Cf-PWV measurement were obtained in 154
patients.
Results: A signiﬁcant correlation between radiotherapy dose and: MeanMax-
IMT (r=0.20; p<0.05), Tmax (r=0.20; p<0.05), distensibility (r=0.24; p<0.05),
DC (r=0.24; p<0.05), CC (r=0.24; p<0.05) was observed. Patients were divided
into 4 groups according to radiotherapy dose (Dose: 20–30; 31–36; 37–42; >42
Gy). An increase in Tmax (1.27±0.61, 1.35±0.59, 1.46±0.69, 1.76±1.12 mm, p
for trend<0.05) and in the prevalence of carotid plaque (29%, 31%, 47% and
55%, p for trend<0.05) was observed as related to dose-category. One-hundred-
seventeen patients received neck irradiation (67 bilateral; 50 unilateral). In unilat-
erally irradiated patients, MeanMaxIMT was greater in the irradiated side as com-
pared to unirradiated carotid artery and the difference reached statistical signiﬁ-
cance in the group of patients who received a high radiotherapy dose (0.97±0.35
vs 0.92±0.34 p<0.05). Cf-PWV was signiﬁcantly greater only in patients that re-
ceived high dose (>42 Gy), as compared to all the other dose groups (9.7±2.3 vs
8.3±2.2, 8.0±1.5 and 8.3±1.4, p<0.05).
Conclusions: In this large number of Hodgkin Lymphoma survivors, carotid IMT,
plaque prevalence and aortic and carotid stiffness were signiﬁcantly related with
radiotherapy doses. Carotid IMT, carotid and aortic stiffness were signiﬁcantly
higher in the irradiated carotid arteries, but only at doses >42 Gy, suggesting that
there may be a dose threshold for radiotherapy-induced carotid wall damage.
P435 | BEDSIDE
Carotid intraplaque hemorrhage and/or plaque rupture may occur at
any time irrespective of symptoms
M.C. Lorenzo1, M. Otero-Losada2, J. Balassanian1, J. Milei2. 1Centro Medicus
de Diagnóstico, Cardiología, Buenos Aires, Argentina; 2Institute of Cardiological
Research. Univ of Buenos Aires. Natl Res Council. ININCA.UBA.CONICET,
Buenos Aires, Argentina
Introduction: This study analyzes the relation between carotid plaque pathology
and the presence of symptoms in a sample of CEA specimens.
Methods: Data from 261 endarterectomies performed over 5 years included full
clinical data, primary risk factors, and pre-surgery color doppler ultrasound and
CT recordings. Patients were classiﬁed as symptomatic or asymptomatic accord-
ing with: transient ipsilateral hemispheric ischemic attack, amaurosis fugax, or
nondisabling stroke within the previous 6 months. Tissue specimens were con-
ventionally processed for histopathology, 3μm sections were stained with H-E,
Mallory’s trichome, Alcian blue and Movat’spentachrome. Plaques were classi-
ﬁed as “complicated” [any of: plaque rupture plus thrombosis, plaque rupture plus
intraplaque hemorrhage (IPH) plus thrombosis, plaque rupture plus IPH, calciﬁed
ulcerated plaque, IPH without plaque rupture] or “non-complicated” (none of the
above).
Results: The analysis identiﬁed 126 symptomatic patients and 135 asymp-
tomatic patients. The prevalence of complicated plaques was not different be-
tween groups: 74.6% (94/126) and 74.8% (101/135) respectively (F1,260 = 0.360,
p<0.549, N.S.). Risk factors were highly prevalent and were not associated with
the presence of symptoms: hypertension (F1,260 = 0.527, p<0.469, N.S.), smok-
ing (F1,260 = 2.442, p<0.119, N.S.), hyperlipidemia (F1,260 = 1.62, p<0.205,
N.S.) and diabetes (F1,260 = 0.684, p<0.409, N.S.) (Table 1). Complications were
not dependent on symptoms (F1,260 = 0.360, p<0.549, N.S.).
Symptomatic (n=126) Asymptomatic (n=135)
Complicated Non complicated Complicated Non complicated
(n=94) (n=32) (n=101) (n=34)
Age (years) 69±8 68±8 67±10 69±10
Male (%) 81 (n=76) 59 (n=19) 77 (n+78) 68 (n=23)
Hypertension (%) 73 (n=69) 75 (n=24) 74 (n=75) 82 (n=28)
Smoking (%) 64 (n=60) 59 (n=19) 59 (n=60) 62 (n=21)
Diabetes (%) 26 (n=24) 19 (n=6) 23 (n=23) 29 (n=10)
Hyperlipidemia (%) 55 (n=52) 69 (n=22) 64 (n=65) 53 (n=18)
3RF (%) 33 (n=31) 19 (n=6) 29 (n=29) 24 (n=8)
3RF: concurrence of at least 3 risk factors.
Conclusion: As expected, symptomatic patients showed high prevalence of pri-
mary risk factors and complicated plaques. Interestingly, asymptomatic patients
were not comparatively different in this regard. Present ﬁndings suggest that
asymptomatic patients with severe stenosis may be at high clinical risk too for
complicated plaques may occur at any time, irrespective of symptoms.
Acknowledgement/Funding: PIP CONICET 2014-2017
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Durability of stroke prevention using a dual-layer stent system in
carotid revascularization in symptomatic and increased-stroke-risk
asymptomatic patients: 12-month evidence from the PARADIGM
study
P. Musialek1, A. Mazurek1, M. Trystula2, A. Borratynska3, A. Lesniak-Sobelga1,
M. Urbanczyk4, R.P. Banys4, P. Wilkolek1, M. Brozda1, N. Dluzniewska1,
A. Brzychczy2, W. Zajdel5, L. Partyka6, K. Zmudka5, P. Podolec1 on behalf of
PARADIGM Study Group. 1Jagiellonian University, John Paul II Hospital, Dept of
Cardiac & Vascular Diseases, Krakow, Poland; 2John Paul II Hospital, Dept. of
Vascular Surgery, Krakow, Poland; 3John Paul II Hospital, Neurology Outpatient
Dept., John Paul II Hospital, Krakow, Poland; 4John Paul II Hospital, Dept. of
Radiology, Krakow, Poland; 5Jagiellonian University, John Paul II Hospital, Dept
of Interventional Cardiology, Krakow, Poland; 6KCRI, Krakow, Poland
Background: Routine diffusion-weighted cerebral imaging and clinical data have
indicated that CGuard™ MicroNET-Covered embolic prevention stent system ef-
fectively minimizes cerebral embolization in carotid artery stenting (CAS) peri-
procedurally and up to 30 days but long-term safety and efﬁcacy has not been
determined.
Purpose: To provide 12-month clinical (including neurologic) and duplex ultra-
sound (DUS) evaluation of CGuard routine use to perform CAS in all-comer
(no exclusion criteria) patients with symptomatic or increased-stroke-risk asymp-
tomatic carotid stenosis (CS) recommended for revascularization by the Neu-
roVascular Team (neurologist + angiologist + vascular surgeon + cardiologist)
committee in a cohort of 100 consecutive CAS patients.
Methods: We performed a non-industry-funded, prospective academic study in
all-referrals-tracked symptomatic and asymptomatic CS. In asymptomatic CS, in-
tervention was mandated only in case of increased-stroke-risk features. Indepen-
dent neurologist evaluation was before CAS, at 48h, 30 days, and 12 months.
DUS was performed at baseline, 30 days and 12 months. There was external
source data veriﬁcation, external angiographic corelab, and external statistical
analysis.
Results: Over 11 months, 108 referrals were NeuroVascular Team-recom-
mended for revascularization. Carotid endarterectomy (CEA) was performed in
7 subjects while 101 patients (51–86 years, 54.5% symptomatic, evolving stroke
in 9) underwent 106 neuroprotected CAS (100% CGuard use, no other stent
types used during the study period). Angiographic diameter stenosis was reduced
from 83±9% to only 6.7±5% (p<0.001, “CEA-like” effect of CAS). Peri-procedural
death/major stroke/MI was 0%. One event, (extension if prior cerebral infarct on
imaging, in a patient with prolonged hypotension) with no change in NIH-SS or
Rankin scale and no clinical sequel, was Clinical Events Committee-adjudicated
as minor stroke (0.9%). By 30 days there were no new events (0%). The clinical,
neurological and DUS follow-up at 12 months was 100%. Between 30 days and
12 months, there were no stroke deaths or strokes (0%) and no MIs (0%); there
was 1 heart failure death and 3 non-cardiac deaths (urosepsis, cancer, pulmonary
embolism). One asymptomatic in-stent restenosis occurred at 12 months; this
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